NON-ENGRAFTMENT AFTER ABMT CAN BE REVERSIBLE ON CD8 INVIVO THERAPY

被引：0
|
作者：
FAVROT, MC
PHILIP, T
MORISSET, J
COMBARET, V
BERNARD, A
机构：
[1] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[2] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1987年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [31] Commensal bacteria that can induce CD8 T cells and cancer immunity
    Tanoue, Takeshi
    Atarashi, Koji
    Honda, Kenya
    CANCER SCIENCE, 2018, 109 : 348 - 348
  • [32] Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
    Serrano-Villar, Sergio
    Martinez-Sanz, Javier
    Ron, Raquel
    Talavera-Rodriguez, Alba
    Fernandez-Felix, Borja M.
    Herrera, Sabina
    Muriel, Alfonso
    Fanjul, Francisco
    Portilla, Joaquin
    Munoz, Josefa
    Amador, Concha
    Alberto de Zarraga, Miguel
    Vivancos, Maria J.
    Moreno, Santiago
    LANCET HIV, 2020, 7 (08): : E565 - E573
  • [33] Non-coding RNAs in CD8 T cell biology
    Wells, Alexandria C.
    Pobezinskaya, Elena L.
    Pobezinsky, Leonid A.
    MOLECULAR IMMUNOLOGY, 2020, 120 : 67 - 73
  • [34] Human CD8[+]TCR[-] Facilitating Cells Enhance HSC Engraftment In Vivo and Promote HSC Survival In Vitro
    Huang, Y.
    Elliott, M.
    Yolcu, E.
    Miller, T.
    Bozulic, L.
    Wen, Y.
    Xu, H.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Differential modulation of CD8β by rat γδ and αβ T cells after activation
    Straube, F
    Herrmann, T
    IMMUNOLOGY, 2001, 104 (03) : 252 - 258
  • [36] CD4 AND CD8 EXPRESSION OF LARGE GRANULAR LYMPHOCYTES AFTER BONE-MARROW TRANSPLANTATION AND ITS EFFECT ON LYMPHOCYTE CD4/CD8 RATIO
    LESKINEN, R
    APMIS, 1993, 101 (02) : 149 - 153
  • [37] Dog leukocyte antigen nonidentical unrelated canine marrow grafts: Enhancement of engraftment by CD4 and CD8 T cells
    Panse, JP
    Bastianelli, C
    Santos, EB
    Schwarzinger, I
    Raff, RF
    Storb, R
    Sandmaier, BM
    TRANSPLANTATION, 2003, 76 (03) : 474 - 480
  • [38] No decrease in CD4/CD8 ratio after 36 months therapy in patients switched to dual regimens containing rilpivirine
    Tortajada, Cecilia
    Castellano, Lidia
    Mengual, Amando
    Flores, Juan
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2021, 39 (02): : 106 - 107
  • [39] CD4 cells can be more efficient at tumor rejection than CD8 cells
    Perez-Diez, A
    Joncker, N
    Choi, K
    Chan, W
    Anderson, C
    Lantz, O
    Matzinger, P
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 617 - 617
  • [40] CD4 cells can be more efficient at tumor rejection than CD8 cells
    Perez-Diez, A
    Matzinger, P
    Lab, G
    FASEB JOURNAL, 2003, 17 (07): : C74 - C75
12345